VIRGINIA BEACH, Va., Nov. 19, 2014 /PRNewswire-USNewswire/ -- A Virginia federal jury awarded LifeNet Health® $34.7 million in damages on Tuesday for LifeCell® Corp.'s infringement of a LifeNet Health patent related to improving the preservation of tissue grafts, and rejected LifeCell's assertions that the patent was invalid. LifeNet Health's patent relates to enabling tissue grafts to be "ready to use" and stored at room temperature while maintaining normal texture and lowering the chance of graft failure.
The jury found that LifeCell's AlloDerm® Ready to Use Regenerative Tissue Matrix and Strattice™ skin graft products infringed all seven asserted claims of LifeNet Health's patent. The LifeCell products are typically used in abdominal wall repair, breast reconstruction and for orthopedic surgical procedures.
Douglas B. Wilson, LifeNet Health's Executive Vice President explained "We're happy to have the jury recognize the value of LifeNet Health's technology and look forward to development of future technologies that help further its goals of saving lives and restoring health."
About LifeNet Health
LifeNet Health helps to save lives and restore health for thousands of patients each year. LifeNet Health is world's most trusted provider of transplant solutions, from organ procurement to new innovations in bio-implant technologies and cellular therapies—a leader in the field of regenerative medicine, while always honoring the donors and healthcare professionals that allow the healing process. For more information about LifeNet Health, go to www.LifeNetHealth.org.
SOURCE LifeNet Health